Page 2 - Clinical Value News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Value Today - Breaking & Trending Today

Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors

Published: January 9, 2022

/PRNewswire/ -- Today, Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical...

Source: prnewswire.com

Related Topics:

Shen LinChris LuYue YongEli LillyUniversity HospitalNational Reimbursement Drug ListDepartment Of Gastrointestinal OncologyNational Medical Products AdministrationCancer InstituteLaekna TherapeuticsDrug EvaluationPrincipal InvestigatorProfessor Shen LinVice PresidentPeking University HospitalLaekna TherapeuticChief Medical OfficerTherapeutics ChairmanGuiding PrinciplesClinical ResearchAntitumor Pharmaceuticals BasedClinical ValueBiologics License ApplicationHealth Care Amp Hospitals Pharmaceuticals